Press Releases

Debiopharm International SA announces results of 2 key oncology programs at 2015 AACR Conference

Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital

Debiopharm Group regains full rights to Alisporivir program

FDA Grants Fast Track designation to Debiopharm Group’s antibiotic Debio 1450

Debiopharm Investment, Ardian, Nixdorf Foundation and Bernis today acquire Eco Delta solar activities

Debiopharm Investment becomes a minority shareholder in Haut-Lac International Bilingual School in St-Légier (VD)

Debiopharm Group™ presents advances of two key oncology clinical programs at the 26th EORTC-NCI-AACR symposium in Barcelona

Coorpacademy, établi à l’EPFL et l’un des leaders des MOOCs à destination des entreprises, lève 3,2 millions d’euros auprès de…

Debiopharm Group™ s’engage auprès du TELETHON avec un partenariat de soutien